GLP-1 Therapy for Medical Weight Loss in Houston, TX

GLP-1 medications have changed the medical approach to weight management by targeting biological pathways that regulate appetite, fullness, digestion, and blood sugar. When combined with nutrition, physical activity, and ongoing medical care, these medications can help appropriate patients achieve meaningful weight loss while addressing some of the metabolic factors that make long-term weight management difficult.

Texas Aesthetics & Bariatrics is led by Ricardo M. Bonnor, MD, FACS, a bariatric surgeon with more than 20 years of experience treating obesity and metabolic disease. That background allows medical weight loss to be approached as part of a broader range of options, from non-surgical treatment to bariatric surgery when appropriate. For patients in Houston and Katy, GLP-1 therapy offers a physician-supervised option tailored to individual health needs and weight-loss goals.

What Is GLP-1 Therapy?

GLP-1 stands for glucagon-like peptide-1, a naturally occurring hormone involved in appetite regulation, digestion, and blood sugar control. Medications that act on this pathway can reduce hunger and help patients feel satisfied with smaller portions.

Semaglutide is a GLP-1 receptor agonist. Tirzepatide acts on both GIP and GLP-1 receptors, giving it a somewhat different mechanism of action.

For chronic weight management, FDA-approved options include Wegovy (semaglutide) and Zepbound (tirzepatide). Ozempic and Mounjaro contain the same respective active ingredients but have different FDA-approved indications, including treatment of type 2 diabetes.

How Does GLP-1 Therapy Support Weight Loss?

These medications can support weight loss through several complementary effects:

Medication is only one component of treatment. Long-term results still depend on nutrition, physical activity, preserving lean muscle, and developing habits that can continue beyond medication use.

Who May Be a Candidate for GLP-1 Therapy?

GLP-1-based weight-management medications may be considered for adults with obesity or for adults who are overweight and have qualifying weight-related health concerns. For example, Zepbound is indicated for adults with obesity or those who are overweight with at least one weight-related condition.

Treatment may also be worth discussing for patients who:

A medical evaluation helps determine whether medication, surgery, or another approach is appropriate.

Semaglutide vs. Tirzepatide

Semaglutide and tirzepatide can both be used for weight management, but they are not identical.

Semaglutide works through the GLP-1 receptor and is available as Wegovy for chronic weight management. Tirzepatide activates both GIP and GLP-1 receptors and is available as Zepbound for chronic weight management.

The appropriate medication depends on factors such as medical history, current medications, previous treatment response, side-effect tolerance, and individual goals. Treatment should be selected after medical evaluation rather than based solely on expected weight loss.

What Are the Side Effects and Safety Considerations?

Common side effects of GLP-1-based medications include nausea, diarrhea, vomiting, constipation, abdominal discomfort, and other gastrointestinal symptoms. Hair loss has also been reported with Zepbound.

Semaglutide and tirzepatide products used for weight management carry boxed warnings involving thyroid C-cell tumors observed in animal studies. They are contraindicated in patients with a personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2.

Discuss pregnancy planning before treatment. Current Wegovy labeling recommends stopping semaglutide at least two months before a planned pregnancy because of its long half-life.

Frequently Asked Questions About GLP-1 Therapy

Some patients notice appetite changes relatively early in treatment, while weight changes develop progressively as the medication is titrated and lifestyle changes are established. Results and timelines vary considerably between patients.

Why Choose Texas Aesthetics & Bariatrics for GLP-1 Therapy?

Ricardo M. Bonnor, MD, FACS, leads medical weight loss at Texas Aesthetics & Bariatrics, with experience across bariatric surgery, metabolic disease, medical weight management, and post-surgical care. This breadth is particularly valuable for patients who need more than a stand-alone prescription.

Initial evaluation can include medical history review, laboratory testing, and body composition assessment to help determine an appropriate approach. Patients who previously underwent bariatric surgery can also be evaluated for medication-based treatment, revision surgery, or other options when weight regain occurs. Because the practice provides both surgical and non-surgical weight management, patients in Houston and Katy can receive coordinated care as their needs change over time.

Build a Medical Weight Loss Plan in Houston & Katy, TX

GLP-1 therapy can be a valuable option for appropriate patients who need additional support with appetite, weight, and metabolic health. Texas Aesthetics & Bariatrics provides physician-directed medical weight management for patients throughout Houston, Katy, and surrounding communities. Call (281) 579-5638 to schedule a consultation (opens in new tab) and discuss whether GLP-1 therapy, bariatric surgery, or another weight-management strategy fits your needs. The goal is to create a plan that supports both meaningful weight loss and long-term health.

Begin Your Journey With Us.

What happens in a consultation?

How May We Help?

*All indicated fields must be completed.

Please include non-medical questions and correspondence only.